These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5757162)

  • 1. [Electrolyte metabolism in patients with toxic goiter and its dynamics in radioiodine therapy].
    Trusov VV; Pevchikh VV
    Probl Endokrinol (Mosk); 1968; 14(2):39-42. PubMed ID: 5757162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the content of electrolytes under the effect of radioiodine therapy of patients with diffuse toxic goiter in association with a severe form of thyrotoxicosis].
    Lipets AI; Dozorets IL
    Med Radiol (Mosk); 1971 Sep; 16(9):23-6. PubMed ID: 5172424
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of iodine deficiency upon PBI in hyperthyroidism.
    Pineda G; Silva E; Gianetti A; Stevenson C; Barzelatto J
    J Clin Endocrinol Metab; 1970 Jan; 30(1):120-4. PubMed ID: 5294083
    [No Abstract]   [Full Text] [Related]  

  • 4. [The interrelationship between electrolytes and phase analysis of systole in toxic goiter].
    Selivonenko VG
    Probl Endokrinol (Mosk); 1975; 21(1):19-23. PubMed ID: 1173461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why not radioiodine therapy for toxic nodular goiter?
    Hamburger JI; Kadian G; Rossin HW
    Arch Intern Med; 1967 Jan; 119(1):75-9. PubMed ID: 6071164
    [No Abstract]   [Full Text] [Related]  

  • 6. [OUR OWN RESULTS IN THE RADIOIODINE THERAPY OF HYPERTHYROIDISM].
    HENNIG K
    Dtsch Gesundheitsw; 1965 May; 20():822-7. PubMed ID: 14306625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamics of sodium and potassium metabolism in patients with various forms of goiter before and after operation].
    Kovalev MM; Morozova DP
    Probl Endokrinol (Mosk); 1969; 15(4):8-13. PubMed ID: 5368720
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON FRACTIONAL RADIOIODINE TREATMENT OF THYROTOXICOSIS].
    FRIDRICH R; WALSER A
    Schweiz Med Wochenschr; 1965 Mar; 95():413-6. PubMed ID: 14277008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
    Anestiadi ZG
    Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrolyte (potassium, sodium) levels in plasma and erythrocytes in thyrotoxicosis].
    Prudnikova RV
    Vrach Delo; 1967; 9():34-6. PubMed ID: 5621775
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of a radioiodine therapy, in hyperthyroidism with and without interval therapy].
    Reinwein D; Horster FA; Klein E; Oberdisse K
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2314-8. PubMed ID: 5696570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrolyte in balance in diffuse toxic goiter].
    Lipets AI
    Probl Endokrinol (Mosk); 1973; 19(3):16-8. PubMed ID: 4125045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131].
    Slukhaĭ IuF
    Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hyperthyroidism with radioiodine: some pertinent observations.
    Sharma SM; Ganatra RD; Shahani SN; Antia FP
    J Assoc Physicians India; 1969 Aug; 17(8):485-91. PubMed ID: 5347683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood sodium and potassium levels in patients with euthyroid and thyrotoxic goiter].
    Kandrenkova NA
    Klin Med (Mosk); 1966 Aug; 44(8):120-3. PubMed ID: 5995808
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term changes in thyroidal clearance rate after radioiodine therapy.
    Myhill J; Hales I; Figgis P; Dvoskin R
    J Clin Endocrinol Metab; 1968 Jan; 28(1):66-72. PubMed ID: 5635449
    [No Abstract]   [Full Text] [Related]  

  • 18. [Criteria for the fractional radioiodine therapy of hyperthyroidism].
    Reinwein D; Klein E; Horster FA; Gabe D
    Verh Dtsch Ges Inn Med; 1967; 73():372-5. PubMed ID: 5591779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood protein, protein fractions, and sialic acids content in patients with thyrotoxicosis treated with radioactive iodine].
    Udod VM; Kuz'mak NI
    Probl Endokrinol (Mosk); 1967; 13(1):8-11. PubMed ID: 5620088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic results of radioiodine therapy (I-131) in hyperthroidism].
    Langbein W
    Radiobiol Radiother (Berl); 1967; 8(5):557-69. PubMed ID: 5603668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.